In Focus channel feed – Endpoints News

In Focus channel feed

A biotech paused a gene therapy hatched by families. Now they want control

3 years ago

Father starts lab after intellectual property issues stymie rare disease drug development

3 years ago

Even as pandemic recedes, short-staffed trial sites leave cancer patients waiting

3 years ago

China's DNA giant confronts skepticism in US expansion bid

3 years ago

After years of failures, the hunt for a new type of Parkinson’s drug is on

3 years ago

Biotech's 'sugar high' led to a correction, but winter doldrums could make way for a turnaround story this fall

3 years ago

Biotech’s downturn fuels a billionaire’s niche investment industry

3 years ago

Those big billion-dollar PhIII studies? Martin Landray says they can be done for a tiny fraction of the cost

3 years ago

Why non-opioid pain drugs keep failing — and what's next for the field

3 years ago

An MIT professor's rare disease quest ripples throughout biotech

3 years ago

After Roe, startups seek to fill Big Pharma’s male contraception gap

3 years ago

After abortion ruling, biotechs behind novel contraceptives say tide is turning on insurance coverage

3 years ago

DNA sequencing giant Illumina battles antitrust regulators and growing competition

3 years ago

How prepared is biopharma for the cyber doomsday?

3 years ago

A new era of treatment: How biomarkers are changing the way we think about cancer

4 years ago

Scientists are finally learning how to design proteins from scratch. Drug development may never be the same

4 years ago

Is this Silicon Valley duo the future of biotech?

4 years ago

Can this tick biologist and her team of ‘weirdo science’ enthusiasts change the future of scientific research?

4 years ago

'Empathy and love were not shown’: The story behind Taysha’s layoffs, one of dozens of biotechs suffering this year’s bear market

4 years ago

After Covid-19 success, patients with the world’s ‘most stigmatized’ infection push for their own Operation Warp Speed

4 years ago

Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment

4 years ago

Inside the race to make psychedelics 'mainstream medicines'

4 years ago

Ahead of FDA committee to discuss new ALS drug, the jury remains out on how much benefit is enough for approval

4 years ago

Covid vaccines and drugs are free. But for many immunocompromised patients, protection comes at a cost

4 years ago

First page Previous page 2 3 456 7 8 Next page Last page